Abeona Therapeutics Inc. (ABEO) vs Eupraxia Pharmaceuticals Inc. (EPRX)
A side-by-side comparison of Abeona Therapeutics Inc. and Eupraxia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.02HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
EPRX
Eupraxia Pharmaceuticals Inc.
$7.85HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — ABEO vs EPRX
growth of $100 · dividends reinvested · last 2yABEO -30.6% (-16.7%/yr)EPRX +162.7% (+62.1%/yr)EPRX compounded faster over this window
ABEO EPRX
ABEO vs EPRX: by the numbers
- •ABEO is the larger company ($286M vs $263M market cap).
- •Both run net losses; EPRX's is the smaller (0.00% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | EPRX |
|---|---|---|
| P/S ratio | 11.20 | N/A |
| P/B ratio | 2.23 | 2.59 |
Profitability
| Metric | ABEO | EPRX |
|---|---|---|
| Gross margin | 73.68% | 0.00% |
| Operating margin | -1536.91% | 0.00% |
| Net margin | -246.42% | 0.00% |
| ROE | -49.11% | -38.33% |
| ROIC | -49.76% | -43.56% |
Growth (annualized)
| Metric | ABEO | EPRX |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| Total return CAGR (5Y) | -26.46% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.